2. The dendritic state;
3. Synthetic methodologies;
4. Characterization methodologies;
5. Biopharmaceutical applications and products;
6. Toxicology of dendrimers and dendrons;
7. The dendritic effect;
8. Dendrons and dendrimers: quantized dendritic building blocks leading to a new nano-periodic system;
9. The past, present and future for dendrimers and dendrons.
Donald A. Tomalia is presently Director of the National Dendrimer and Nanotechnology Center and Founder/President of NanoSynthons, LLC. He is internationally recognized as a pioneer in dendrimers, dendritic polymers, dendrimer-based nanomedicine and a new nano-periodic system for defining and unifying nanoscience. Active in both academia and industry, Tomalia is an Associate Editor of Nanomedicine (Elsevier), the founder of several dendrimer production companies including, most recently, NanoSynthons, LLC (2010) and Dendritic Nanotechnologies, Inc. (2001), a subsidiary of Starpharma.
Jørn B. Christensen University of Copenhagen.
J�rn B. Christensen is an Associate Professor in the Department of Chemistry at the University of Copenhagen. He has a background in organic chemistry and has worked in many different areas ranging from organic superconductors to non-antibiotics.
Ulrik Boas Technical University of Denmark, Lyngby.
Ulrik Boas is an Associate Professor in the National Veterinary Institute at the Technical University of Denmark. He received his Ph.D. in Organic and Macromolecular Chemistry in 2002, prior to which he gained several years of experience working in the biotechnology industry.